PYODERMA GANGRENOSUM
Clinical trials for PYODERMA GANGRENOSUM explained in plain language.
Never miss a new study
Get alerted when new PYODERMA GANGRENOSUM trials appear
Sign up with your email to follow new studies for PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to heal painful, Hard-to-Treat skin wounds
Disease control Not yet recruitingThis study is testing an investigational injection called SHR-1139 to see if it can help heal painful skin ulcers in adults with a condition called pyoderma gangrenosum. It will enroll about 10 participants to measure how well the injection closes the ulcers over 12 weeks and mon…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New drug tested for healing painful, Hard-to-Treat skin wounds
Disease control Not yet recruitingThis study is testing an investigational injection called SHR-1139 in adults with pyoderma gangrenosum, a painful condition causing severe skin ulcers. The main goal is to see if the treatment can completely close these ulcers and keep them closed. Researchers will also monitor s…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Oxygen chamber trial tests hope for dozens of Tough-to-Treat illnesses
Disease control Not yet recruitingThis study is gathering information to see how well hyperbaric oxygen therapy (HBOT) works for over 40 different health conditions. It will enroll about 100 people who have been referred for HBOT for conditions like Long COVID, Crohn's disease, and various ulcers. The main goal i…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC